nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—Alkylating Activity—Dacarbazine—muscle cancer	0.529	1	CiPCiCtD
Thiotepa—hematologic cancer—muscle cancer	0.18	0.438	CtDrD
Thiotepa—urinary bladder cancer—muscle cancer	0.138	0.336	CtDrD
Thiotepa—sarcoma—muscle cancer	0.0931	0.227	CtDrD
Thiotepa—CYP2B6—Doxorubicin—muscle cancer	0.00536	0.445	CbGbCtD
Thiotepa—CYP3A4—Vincristine—muscle cancer	0.00263	0.219	CbGbCtD
Thiotepa—CYP3A4—Etoposide—muscle cancer	0.00241	0.2	CbGbCtD
Thiotepa—CYP3A4—Doxorubicin—muscle cancer	0.00164	0.137	CbGbCtD
Thiotepa—Colitis—Doxorubicin—muscle cancer	8.52e-05	0.00176	CcSEcCtD
Thiotepa—Urinary tract disorder—Etoposide—muscle cancer	8.49e-05	0.00175	CcSEcCtD
Thiotepa—Agitation—Vincristine—muscle cancer	8.49e-05	0.00175	CcSEcCtD
Thiotepa—Skin exfoliation—Doxorubicin—muscle cancer	8.47e-05	0.00175	CcSEcCtD
Thiotepa—Fluid retention—Doxorubicin—muscle cancer	8.43e-05	0.00174	CcSEcCtD
Thiotepa—Urethral disorder—Etoposide—muscle cancer	8.42e-05	0.00174	CcSEcCtD
Thiotepa—Infection—Dactinomycin—muscle cancer	8.38e-05	0.00173	CcSEcCtD
Thiotepa—Blood urea increased—Doxorubicin—muscle cancer	8.38e-05	0.00173	CcSEcCtD
Thiotepa—Hepatic failure—Methotrexate—muscle cancer	8.28e-05	0.00171	CcSEcCtD
Thiotepa—Leukopenia—Vincristine—muscle cancer	8.27e-05	0.0017	CcSEcCtD
Thiotepa—Thrombocytopenia—Dactinomycin—muscle cancer	8.26e-05	0.0017	CcSEcCtD
Thiotepa—Oesophagitis—Doxorubicin—muscle cancer	8.11e-05	0.00167	CcSEcCtD
Thiotepa—Anorexia—Dactinomycin—muscle cancer	8.04e-05	0.00166	CcSEcCtD
Thiotepa—Eye disorder—Etoposide—muscle cancer	8.03e-05	0.00166	CcSEcCtD
Thiotepa—Bladder pain—Doxorubicin—muscle cancer	8.02e-05	0.00165	CcSEcCtD
Thiotepa—Convulsion—Vincristine—muscle cancer	8e-05	0.00165	CcSEcCtD
Thiotepa—Cardiac disorder—Etoposide—muscle cancer	7.97e-05	0.00164	CcSEcCtD
Thiotepa—Hypertension—Vincristine—muscle cancer	7.97e-05	0.00164	CcSEcCtD
Thiotepa—Pulmonary oedema—Doxorubicin—muscle cancer	7.9e-05	0.00163	CcSEcCtD
Thiotepa—Myalgia—Vincristine—muscle cancer	7.86e-05	0.00162	CcSEcCtD
Thiotepa—Angiopathy—Etoposide—muscle cancer	7.8e-05	0.00161	CcSEcCtD
Thiotepa—Immune system disorder—Etoposide—muscle cancer	7.76e-05	0.0016	CcSEcCtD
Thiotepa—Mediastinal disorder—Etoposide—muscle cancer	7.74e-05	0.0016	CcSEcCtD
Thiotepa—Chills—Etoposide—muscle cancer	7.71e-05	0.00159	CcSEcCtD
Thiotepa—Sepsis—Doxorubicin—muscle cancer	7.7e-05	0.00159	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Dactinomycin—muscle cancer	7.68e-05	0.00158	CcSEcCtD
Thiotepa—Alopecia—Etoposide—muscle cancer	7.59e-05	0.00157	CcSEcCtD
Thiotepa—Infection—Vincristine—muscle cancer	7.49e-05	0.00154	CcSEcCtD
Thiotepa—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	7.41e-05	0.00153	CcSEcCtD
Thiotepa—Nervous system disorder—Vincristine—muscle cancer	7.39e-05	0.00152	CcSEcCtD
Thiotepa—Thrombocytopenia—Vincristine—muscle cancer	7.38e-05	0.00152	CcSEcCtD
Thiotepa—Decreased appetite—Dactinomycin—muscle cancer	7.33e-05	0.00151	CcSEcCtD
Thiotepa—Fatigue—Dactinomycin—muscle cancer	7.27e-05	0.0015	CcSEcCtD
Thiotepa—Back pain—Etoposide—muscle cancer	7.24e-05	0.00149	CcSEcCtD
Thiotepa—Pain—Dactinomycin—muscle cancer	7.21e-05	0.00149	CcSEcCtD
Thiotepa—Anorexia—Vincristine—muscle cancer	7.18e-05	0.00148	CcSEcCtD
Thiotepa—Hepatic failure—Doxorubicin—muscle cancer	7.17e-05	0.00148	CcSEcCtD
Thiotepa—Ataxia—Methotrexate—muscle cancer	7e-05	0.00144	CcSEcCtD
Thiotepa—Feeling abnormal—Dactinomycin—muscle cancer	6.95e-05	0.00143	CcSEcCtD
Thiotepa—Anaemia—Etoposide—muscle cancer	6.91e-05	0.00143	CcSEcCtD
Thiotepa—Gastrointestinal pain—Dactinomycin—muscle cancer	6.9e-05	0.00142	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Vincristine—muscle cancer	6.87e-05	0.00142	CcSEcCtD
Thiotepa—Paraesthesia—Vincristine—muscle cancer	6.77e-05	0.00139	CcSEcCtD
Thiotepa—Leukopenia—Etoposide—muscle cancer	6.7e-05	0.00138	CcSEcCtD
Thiotepa—Abdominal pain—Dactinomycin—muscle cancer	6.67e-05	0.00137	CcSEcCtD
Thiotepa—Body temperature increased—Dactinomycin—muscle cancer	6.67e-05	0.00137	CcSEcCtD
Thiotepa—Cardiac failure—Doxorubicin—muscle cancer	6.6e-05	0.00136	CcSEcCtD
Thiotepa—Decreased appetite—Vincristine—muscle cancer	6.55e-05	0.00135	CcSEcCtD
Thiotepa—Cough—Etoposide—muscle cancer	6.53e-05	0.00135	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Vincristine—muscle cancer	6.51e-05	0.00134	CcSEcCtD
Thiotepa—Fatigue—Vincristine—muscle cancer	6.5e-05	0.00134	CcSEcCtD
Thiotepa—Convulsion—Etoposide—muscle cancer	6.48e-05	0.00134	CcSEcCtD
Thiotepa—Hypertension—Etoposide—muscle cancer	6.46e-05	0.00133	CcSEcCtD
Thiotepa—Constipation—Vincristine—muscle cancer	6.44e-05	0.00133	CcSEcCtD
Thiotepa—Pain—Vincristine—muscle cancer	6.44e-05	0.00133	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	6.32e-05	0.0013	CcSEcCtD
Thiotepa—Hypersensitivity—Dactinomycin—muscle cancer	6.21e-05	0.00128	CcSEcCtD
Thiotepa—Gastrointestinal pain—Vincristine—muscle cancer	6.16e-05	0.00127	CcSEcCtD
Thiotepa—Confusional state—Etoposide—muscle cancer	6.16e-05	0.00127	CcSEcCtD
Thiotepa—Cardiac arrest—Doxorubicin—muscle cancer	6.13e-05	0.00126	CcSEcCtD
Thiotepa—Pancytopenia—Methotrexate—muscle cancer	6.11e-05	0.00126	CcSEcCtD
Thiotepa—Infection—Etoposide—muscle cancer	6.06e-05	0.00125	CcSEcCtD
Thiotepa—Ataxia—Doxorubicin—muscle cancer	6.06e-05	0.00125	CcSEcCtD
Thiotepa—Asthenia—Dactinomycin—muscle cancer	6.05e-05	0.00125	CcSEcCtD
Thiotepa—Blood creatinine increased—Doxorubicin—muscle cancer	6.04e-05	0.00124	CcSEcCtD
Thiotepa—Dysuria—Methotrexate—muscle cancer	6.01e-05	0.00124	CcSEcCtD
Thiotepa—Dehydration—Doxorubicin—muscle cancer	5.99e-05	0.00123	CcSEcCtD
Thiotepa—Thrombocytopenia—Etoposide—muscle cancer	5.98e-05	0.00123	CcSEcCtD
Thiotepa—Tachycardia—Etoposide—muscle cancer	5.96e-05	0.00123	CcSEcCtD
Thiotepa—Body temperature increased—Vincristine—muscle cancer	5.96e-05	0.00123	CcSEcCtD
Thiotepa—Abdominal pain—Vincristine—muscle cancer	5.96e-05	0.00123	CcSEcCtD
Thiotepa—Skin disorder—Etoposide—muscle cancer	5.93e-05	0.00122	CcSEcCtD
Thiotepa—Anorexia—Etoposide—muscle cancer	5.82e-05	0.0012	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	5.8e-05	0.0012	CcSEcCtD
Thiotepa—Diarrhoea—Dactinomycin—muscle cancer	5.77e-05	0.00119	CcSEcCtD
Thiotepa—Pneumonia—Methotrexate—muscle cancer	5.77e-05	0.00119	CcSEcCtD
Thiotepa—Infestation NOS—Methotrexate—muscle cancer	5.73e-05	0.00118	CcSEcCtD
Thiotepa—Infestation—Methotrexate—muscle cancer	5.73e-05	0.00118	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Doxorubicin—muscle cancer	5.68e-05	0.00117	CcSEcCtD
Thiotepa—Renal failure—Methotrexate—muscle cancer	5.64e-05	0.00116	CcSEcCtD
Thiotepa—Stomatitis—Methotrexate—muscle cancer	5.59e-05	0.00115	CcSEcCtD
Thiotepa—Conjunctivitis—Methotrexate—muscle cancer	5.57e-05	0.00115	CcSEcCtD
Thiotepa—Hypersensitivity—Vincristine—muscle cancer	5.55e-05	0.00114	CcSEcCtD
Thiotepa—Paraesthesia—Etoposide—muscle cancer	5.48e-05	0.00113	CcSEcCtD
Thiotepa—Haematuria—Methotrexate—muscle cancer	5.47e-05	0.00113	CcSEcCtD
Thiotepa—Somnolence—Etoposide—muscle cancer	5.43e-05	0.00112	CcSEcCtD
Thiotepa—Hepatobiliary disease—Methotrexate—muscle cancer	5.42e-05	0.00112	CcSEcCtD
Thiotepa—Epistaxis—Methotrexate—muscle cancer	5.41e-05	0.00111	CcSEcCtD
Thiotepa—Asthenia—Vincristine—muscle cancer	5.41e-05	0.00111	CcSEcCtD
Thiotepa—Vomiting—Dactinomycin—muscle cancer	5.36e-05	0.00111	CcSEcCtD
Thiotepa—Agranulocytosis—Methotrexate—muscle cancer	5.35e-05	0.0011	CcSEcCtD
Thiotepa—Rash—Dactinomycin—muscle cancer	5.32e-05	0.0011	CcSEcCtD
Thiotepa—Decreased appetite—Etoposide—muscle cancer	5.31e-05	0.00109	CcSEcCtD
Thiotepa—Pancytopenia—Doxorubicin—muscle cancer	5.29e-05	0.00109	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Etoposide—muscle cancer	5.27e-05	0.00109	CcSEcCtD
Thiotepa—Fatigue—Etoposide—muscle cancer	5.26e-05	0.00108	CcSEcCtD
Thiotepa—Pain—Etoposide—muscle cancer	5.22e-05	0.00108	CcSEcCtD
Thiotepa—Constipation—Etoposide—muscle cancer	5.22e-05	0.00108	CcSEcCtD
Thiotepa—Dysuria—Doxorubicin—muscle cancer	5.21e-05	0.00107	CcSEcCtD
Thiotepa—Haemoglobin—Methotrexate—muscle cancer	5.17e-05	0.00107	CcSEcCtD
Thiotepa—Diarrhoea—Vincristine—muscle cancer	5.16e-05	0.00106	CcSEcCtD
Thiotepa—Haemorrhage—Methotrexate—muscle cancer	5.15e-05	0.00106	CcSEcCtD
Thiotepa—Urinary tract disorder—Methotrexate—muscle cancer	5.08e-05	0.00105	CcSEcCtD
Thiotepa—Weight increased—Doxorubicin—muscle cancer	5.07e-05	0.00104	CcSEcCtD
Thiotepa—Urethral disorder—Methotrexate—muscle cancer	5.05e-05	0.00104	CcSEcCtD
Thiotepa—Feeling abnormal—Etoposide—muscle cancer	5.03e-05	0.00104	CcSEcCtD
Thiotepa—Hyperglycaemia—Doxorubicin—muscle cancer	5.02e-05	0.00104	CcSEcCtD
Thiotepa—Nausea—Dactinomycin—muscle cancer	5.01e-05	0.00103	CcSEcCtD
Thiotepa—Pneumonia—Doxorubicin—muscle cancer	4.99e-05	0.00103	CcSEcCtD
Thiotepa—Gastrointestinal pain—Etoposide—muscle cancer	4.99e-05	0.00103	CcSEcCtD
Thiotepa—Dizziness—Vincristine—muscle cancer	4.98e-05	0.00103	CcSEcCtD
Thiotepa—Infestation NOS—Doxorubicin—muscle cancer	4.96e-05	0.00102	CcSEcCtD
Thiotepa—Infestation—Doxorubicin—muscle cancer	4.96e-05	0.00102	CcSEcCtD
Thiotepa—Renal failure—Doxorubicin—muscle cancer	4.88e-05	0.00101	CcSEcCtD
Thiotepa—Urticaria—Etoposide—muscle cancer	4.85e-05	0.001	CcSEcCtD
Thiotepa—Stomatitis—Doxorubicin—muscle cancer	4.84e-05	0.000997	CcSEcCtD
Thiotepa—Jaundice—Doxorubicin—muscle cancer	4.84e-05	0.000997	CcSEcCtD
Thiotepa—Abdominal pain—Etoposide—muscle cancer	4.83e-05	0.000995	CcSEcCtD
Thiotepa—Body temperature increased—Etoposide—muscle cancer	4.83e-05	0.000995	CcSEcCtD
Thiotepa—Conjunctivitis—Doxorubicin—muscle cancer	4.83e-05	0.000995	CcSEcCtD
Thiotepa—Eye disorder—Methotrexate—muscle cancer	4.81e-05	0.000991	CcSEcCtD
Thiotepa—Tinnitus—Methotrexate—muscle cancer	4.8e-05	0.000989	CcSEcCtD
Thiotepa—Vomiting—Vincristine—muscle cancer	4.79e-05	0.000988	CcSEcCtD
Thiotepa—Cardiac disorder—Methotrexate—muscle cancer	4.78e-05	0.000985	CcSEcCtD
Thiotepa—Rash—Vincristine—muscle cancer	4.75e-05	0.000979	CcSEcCtD
Thiotepa—Dermatitis—Vincristine—muscle cancer	4.75e-05	0.000978	CcSEcCtD
Thiotepa—Haematuria—Doxorubicin—muscle cancer	4.73e-05	0.000976	CcSEcCtD
Thiotepa—Headache—Vincristine—muscle cancer	4.72e-05	0.000973	CcSEcCtD
Thiotepa—Hepatobiliary disease—Doxorubicin—muscle cancer	4.7e-05	0.000968	CcSEcCtD
Thiotepa—Epistaxis—Doxorubicin—muscle cancer	4.68e-05	0.000965	CcSEcCtD
Thiotepa—Angiopathy—Methotrexate—muscle cancer	4.67e-05	0.000963	CcSEcCtD
Thiotepa—Immune system disorder—Methotrexate—muscle cancer	4.65e-05	0.000958	CcSEcCtD
Thiotepa—Mediastinal disorder—Methotrexate—muscle cancer	4.64e-05	0.000956	CcSEcCtD
Thiotepa—Agranulocytosis—Doxorubicin—muscle cancer	4.63e-05	0.000955	CcSEcCtD
Thiotepa—Chills—Methotrexate—muscle cancer	4.62e-05	0.000952	CcSEcCtD
Thiotepa—Alopecia—Methotrexate—muscle cancer	4.55e-05	0.000937	CcSEcCtD
Thiotepa—Mental disorder—Methotrexate—muscle cancer	4.51e-05	0.000929	CcSEcCtD
Thiotepa—Hypersensitivity—Etoposide—muscle cancer	4.5e-05	0.000927	CcSEcCtD
Thiotepa—Malnutrition—Methotrexate—muscle cancer	4.48e-05	0.000923	CcSEcCtD
Thiotepa—Erythema—Methotrexate—muscle cancer	4.48e-05	0.000923	CcSEcCtD
Thiotepa—Haemoglobin—Doxorubicin—muscle cancer	4.48e-05	0.000923	CcSEcCtD
Thiotepa—Nausea—Vincristine—muscle cancer	4.48e-05	0.000923	CcSEcCtD
Thiotepa—Haemorrhage—Doxorubicin—muscle cancer	4.46e-05	0.000919	CcSEcCtD
Thiotepa—Urinary tract disorder—Doxorubicin—muscle cancer	4.4e-05	0.000907	CcSEcCtD
Thiotepa—Asthenia—Etoposide—muscle cancer	4.38e-05	0.000903	CcSEcCtD
Thiotepa—Connective tissue disorder—Doxorubicin—muscle cancer	4.38e-05	0.000903	CcSEcCtD
Thiotepa—Urethral disorder—Doxorubicin—muscle cancer	4.37e-05	0.0009	CcSEcCtD
Thiotepa—Back pain—Methotrexate—muscle cancer	4.33e-05	0.000893	CcSEcCtD
Thiotepa—Pruritus—Etoposide—muscle cancer	4.32e-05	0.00089	CcSEcCtD
Thiotepa—Vision blurred—Methotrexate—muscle cancer	4.22e-05	0.00087	CcSEcCtD
Thiotepa—Diarrhoea—Etoposide—muscle cancer	4.18e-05	0.000861	CcSEcCtD
Thiotepa—Eye disorder—Doxorubicin—muscle cancer	4.16e-05	0.000858	CcSEcCtD
Thiotepa—Tinnitus—Doxorubicin—muscle cancer	4.16e-05	0.000856	CcSEcCtD
Thiotepa—Anaemia—Methotrexate—muscle cancer	4.14e-05	0.000854	CcSEcCtD
Thiotepa—Cardiac disorder—Doxorubicin—muscle cancer	4.14e-05	0.000853	CcSEcCtD
Thiotepa—Angiopathy—Doxorubicin—muscle cancer	4.04e-05	0.000833	CcSEcCtD
Thiotepa—Dizziness—Etoposide—muscle cancer	4.04e-05	0.000832	CcSEcCtD
Thiotepa—Immune system disorder—Doxorubicin—muscle cancer	4.03e-05	0.00083	CcSEcCtD
Thiotepa—Mediastinal disorder—Doxorubicin—muscle cancer	4.02e-05	0.000828	CcSEcCtD
Thiotepa—Leukopenia—Methotrexate—muscle cancer	4.01e-05	0.000827	CcSEcCtD
Thiotepa—Chills—Doxorubicin—muscle cancer	4e-05	0.000824	CcSEcCtD
Thiotepa—Arrhythmia—Doxorubicin—muscle cancer	3.98e-05	0.000821	CcSEcCtD
Thiotepa—Alopecia—Doxorubicin—muscle cancer	3.94e-05	0.000812	CcSEcCtD
Thiotepa—Cough—Methotrexate—muscle cancer	3.91e-05	0.000806	CcSEcCtD
Thiotepa—Mental disorder—Doxorubicin—muscle cancer	3.9e-05	0.000805	CcSEcCtD
Thiotepa—Convulsion—Methotrexate—muscle cancer	3.88e-05	0.0008	CcSEcCtD
Thiotepa—Vomiting—Etoposide—muscle cancer	3.88e-05	0.0008	CcSEcCtD
Thiotepa—Erythema—Doxorubicin—muscle cancer	3.88e-05	0.0008	CcSEcCtD
Thiotepa—Malnutrition—Doxorubicin—muscle cancer	3.88e-05	0.0008	CcSEcCtD
Thiotepa—Rash—Etoposide—muscle cancer	3.85e-05	0.000793	CcSEcCtD
Thiotepa—Dermatitis—Etoposide—muscle cancer	3.85e-05	0.000793	CcSEcCtD
Thiotepa—Headache—Etoposide—muscle cancer	3.82e-05	0.000788	CcSEcCtD
Thiotepa—Arthralgia—Methotrexate—muscle cancer	3.81e-05	0.000786	CcSEcCtD
Thiotepa—Myalgia—Methotrexate—muscle cancer	3.81e-05	0.000786	CcSEcCtD
Thiotepa—Tension—Doxorubicin—muscle cancer	3.81e-05	0.000785	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	3.79e-05	0.000781	CcSEcCtD
Thiotepa—Nervousness—Doxorubicin—muscle cancer	3.77e-05	0.000777	CcSEcCtD
Thiotepa—Back pain—Doxorubicin—muscle cancer	3.75e-05	0.000774	CcSEcCtD
Thiotepa—Confusional state—Methotrexate—muscle cancer	3.69e-05	0.00076	CcSEcCtD
Thiotepa—Vision blurred—Doxorubicin—muscle cancer	3.66e-05	0.000754	CcSEcCtD
Thiotepa—Infection—Methotrexate—muscle cancer	3.63e-05	0.000749	CcSEcCtD
Thiotepa—Nausea—Etoposide—muscle cancer	3.63e-05	0.000747	CcSEcCtD
Thiotepa—Nervous system disorder—Methotrexate—muscle cancer	3.59e-05	0.000739	CcSEcCtD
Thiotepa—Anaemia—Doxorubicin—muscle cancer	3.59e-05	0.000739	CcSEcCtD
Thiotepa—Thrombocytopenia—Methotrexate—muscle cancer	3.58e-05	0.000738	CcSEcCtD
Thiotepa—Agitation—Doxorubicin—muscle cancer	3.57e-05	0.000735	CcSEcCtD
Thiotepa—Skin disorder—Methotrexate—muscle cancer	3.55e-05	0.000732	CcSEcCtD
Thiotepa—Anorexia—Methotrexate—muscle cancer	3.49e-05	0.000718	CcSEcCtD
Thiotepa—Leukopenia—Doxorubicin—muscle cancer	3.47e-05	0.000716	CcSEcCtD
Thiotepa—Cough—Doxorubicin—muscle cancer	3.39e-05	0.000698	CcSEcCtD
Thiotepa—Convulsion—Doxorubicin—muscle cancer	3.36e-05	0.000693	CcSEcCtD
Thiotepa—Hypertension—Doxorubicin—muscle cancer	3.35e-05	0.00069	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Methotrexate—muscle cancer	3.33e-05	0.000687	CcSEcCtD
Thiotepa—Myalgia—Doxorubicin—muscle cancer	3.3e-05	0.000681	CcSEcCtD
Thiotepa—Arthralgia—Doxorubicin—muscle cancer	3.3e-05	0.000681	CcSEcCtD
Thiotepa—Anxiety—Doxorubicin—muscle cancer	3.29e-05	0.000678	CcSEcCtD
Thiotepa—Paraesthesia—Methotrexate—muscle cancer	3.28e-05	0.000677	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	3.28e-05	0.000676	CcSEcCtD
Thiotepa—Somnolence—Methotrexate—muscle cancer	3.25e-05	0.00067	CcSEcCtD
Thiotepa—Dyspepsia—Methotrexate—muscle cancer	3.22e-05	0.000663	CcSEcCtD
Thiotepa—Confusional state—Doxorubicin—muscle cancer	3.19e-05	0.000658	CcSEcCtD
Thiotepa—Decreased appetite—Methotrexate—muscle cancer	3.18e-05	0.000655	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Methotrexate—muscle cancer	3.16e-05	0.000651	CcSEcCtD
Thiotepa—Fatigue—Methotrexate—muscle cancer	3.15e-05	0.00065	CcSEcCtD
Thiotepa—Infection—Doxorubicin—muscle cancer	3.15e-05	0.000648	CcSEcCtD
Thiotepa—Pain—Methotrexate—muscle cancer	3.13e-05	0.000645	CcSEcCtD
Thiotepa—Nervous system disorder—Doxorubicin—muscle cancer	3.11e-05	0.00064	CcSEcCtD
Thiotepa—Thrombocytopenia—Doxorubicin—muscle cancer	3.1e-05	0.000639	CcSEcCtD
Thiotepa—Tachycardia—Doxorubicin—muscle cancer	3.09e-05	0.000637	CcSEcCtD
Thiotepa—Skin disorder—Doxorubicin—muscle cancer	3.08e-05	0.000634	CcSEcCtD
Thiotepa—Anorexia—Doxorubicin—muscle cancer	3.02e-05	0.000622	CcSEcCtD
Thiotepa—Feeling abnormal—Methotrexate—muscle cancer	3.01e-05	0.000621	CcSEcCtD
Thiotepa—Gastrointestinal pain—Methotrexate—muscle cancer	2.99e-05	0.000616	CcSEcCtD
Thiotepa—Urticaria—Methotrexate—muscle cancer	2.9e-05	0.000599	CcSEcCtD
Thiotepa—Abdominal pain—Methotrexate—muscle cancer	2.89e-05	0.000596	CcSEcCtD
Thiotepa—Body temperature increased—Methotrexate—muscle cancer	2.89e-05	0.000596	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Doxorubicin—muscle cancer	2.88e-05	0.000595	CcSEcCtD
Thiotepa—Paraesthesia—Doxorubicin—muscle cancer	2.84e-05	0.000586	CcSEcCtD
Thiotepa—Somnolence—Doxorubicin—muscle cancer	2.81e-05	0.00058	CcSEcCtD
Thiotepa—Dyspepsia—Doxorubicin—muscle cancer	2.79e-05	0.000574	CcSEcCtD
Thiotepa—Decreased appetite—Doxorubicin—muscle cancer	2.75e-05	0.000567	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Doxorubicin—muscle cancer	2.73e-05	0.000563	CcSEcCtD
Thiotepa—Fatigue—Doxorubicin—muscle cancer	2.73e-05	0.000563	CcSEcCtD
Thiotepa—Pain—Doxorubicin—muscle cancer	2.71e-05	0.000558	CcSEcCtD
Thiotepa—Constipation—Doxorubicin—muscle cancer	2.71e-05	0.000558	CcSEcCtD
Thiotepa—Hypersensitivity—Methotrexate—muscle cancer	2.69e-05	0.000555	CcSEcCtD
Thiotepa—Asthenia—Methotrexate—muscle cancer	2.62e-05	0.000541	CcSEcCtD
Thiotepa—Feeling abnormal—Doxorubicin—muscle cancer	2.61e-05	0.000538	CcSEcCtD
Thiotepa—Gastrointestinal pain—Doxorubicin—muscle cancer	2.59e-05	0.000534	CcSEcCtD
Thiotepa—Pruritus—Methotrexate—muscle cancer	2.59e-05	0.000533	CcSEcCtD
Thiotepa—Urticaria—Doxorubicin—muscle cancer	2.52e-05	0.000518	CcSEcCtD
Thiotepa—Abdominal pain—Doxorubicin—muscle cancer	2.5e-05	0.000516	CcSEcCtD
Thiotepa—Body temperature increased—Doxorubicin—muscle cancer	2.5e-05	0.000516	CcSEcCtD
Thiotepa—Diarrhoea—Methotrexate—muscle cancer	2.5e-05	0.000516	CcSEcCtD
Thiotepa—Dizziness—Methotrexate—muscle cancer	2.42e-05	0.000498	CcSEcCtD
Thiotepa—Hypersensitivity—Doxorubicin—muscle cancer	2.33e-05	0.000481	CcSEcCtD
Thiotepa—Vomiting—Methotrexate—muscle cancer	2.32e-05	0.000479	CcSEcCtD
Thiotepa—Rash—Methotrexate—muscle cancer	2.31e-05	0.000475	CcSEcCtD
Thiotepa—Dermatitis—Methotrexate—muscle cancer	2.3e-05	0.000475	CcSEcCtD
Thiotepa—Headache—Methotrexate—muscle cancer	2.29e-05	0.000472	CcSEcCtD
Thiotepa—Asthenia—Doxorubicin—muscle cancer	2.27e-05	0.000468	CcSEcCtD
Thiotepa—Pruritus—Doxorubicin—muscle cancer	2.24e-05	0.000462	CcSEcCtD
Thiotepa—Nausea—Methotrexate—muscle cancer	2.17e-05	0.000448	CcSEcCtD
Thiotepa—Diarrhoea—Doxorubicin—muscle cancer	2.17e-05	0.000447	CcSEcCtD
Thiotepa—Dizziness—Doxorubicin—muscle cancer	2.09e-05	0.000432	CcSEcCtD
Thiotepa—Vomiting—Doxorubicin—muscle cancer	2.01e-05	0.000415	CcSEcCtD
Thiotepa—Rash—Doxorubicin—muscle cancer	2e-05	0.000411	CcSEcCtD
Thiotepa—Dermatitis—Doxorubicin—muscle cancer	1.99e-05	0.000411	CcSEcCtD
Thiotepa—Headache—Doxorubicin—muscle cancer	1.98e-05	0.000409	CcSEcCtD
Thiotepa—Nausea—Doxorubicin—muscle cancer	1.88e-05	0.000388	CcSEcCtD
